Research progress of therapy for elderly non-transplantation-eligible newly diagnosed multiple myeloma / 白血病·淋巴瘤

ABSTRACT

The mean age of multiple myeloma (MM) patients was 60 years old,most of whom are not eligible for transplantation.Goals for elderly patients is to prolong survival time and ensure quality of life by achieving the best response.Prolonged treatment or maintenance therapy in elderly patients could improve the quality of clinical response and extend progression-free survival.Further study is needed to determine whether novel treatment regimens could improve adverse prognosis of high-risk cytogenetic patients.Optimal individualized regimens should be found to improve tolerability and treatment efficacy.